2020 | |
---|---|
Criterium: | Position: |
Overall Score: | > 1000 |
Total Project Funding per Partner: | 700-800 |
Total Number of Projects: | > 1000 |
Total number of projects: 2
As coordinator: 0
As participant: 1
Sole participant: 1
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2022 | 0 | 12.778.595 | 562.500 | 1 | ||
2020 | 2.500.000 | 0 | 2.500.000 | 1 |
Total number of partners: 7
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 7
Frequent / Rare Partner Ratio: 0
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2022-06-01 | Developing novel inhaled bioengineered Extracellular Vesicle RNA based advanced therapeutics, delivered by tailored aerosol delivery technology for the treatment of lung cancer | INSPIRE | participant | 12.778.595 | 8 |
2020-09-01 | Rapid COVID-19 Passive Therapy Response Platform | RapCo-19 | coordinator | 2.500.000 | 1 |